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Massive cutaneous metastases as a first symptom of breast 
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ABSTRACT 
Introduction: Metastases to the skin are relatively rare, but they are an important diagnostic and therapeutic challenge. In women skin 
metastases are the most commonly associated with breast cancer. In the men they are often associated with lung cancer. Skin metastasis 
most often are in form of blue-purple nodules and tumours with tendency of necrosis. 
Aim: The aim of this paper is to present the case of a patient with diagnosed breast cancer with skin involvement.
Case report: The 48-years old female patient was admitted to The Department of Dermatology for diagnosis and treatment of dermal 
lesions in form of numerous blue-purple nodules and ulcerations localised on the skin of the chest. The ultrasound examination suggested 
a primary malignant lesion in the left breast spreading to the right side and numerous satellite nodules. A whole nodule was collected 
for histopathological and immunohistochemical examinations in order to make the final diagnosis. Histopathology tests confirmed 
the diagnosis of tumour metastases of the skin  and positive immunohistochemical reactions for cytokeratin 7 (CK7) and for oestrogen 
receptors (ER) pointed mammary glands as the primary site. The patient was urgently referred to the Oncology Centre. 
Conclusions: The occurrence of skin metastasis in all tumour processes significantly worsens the prognosis of the patient. These changes 
should be quickly recognized by the oncologist or dermatologist. Sometimes the localization of primary tumour is not possible to deter-
mine without taking the biopsy for histopathological and immunohistochemistry assays. Rapid treatment of appropriate chemotherapy 
or radiotherapy can prolong life and reduce pain.
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STRESZCZENIE
Wstęp: Przerzuty nowotworów do skóry stanowią istotny problem diagnostyczy i terapeutyczny, chociaż występują stosunkowo rzadko. 
Przerzuty do skóry obserwowane są najczęściej w przebiegu raka sutka u kobiet i raka płuca w przypadku mężczyzn. Zazwyczaj mają 
one postać sinofioletowych guzków i guzów, niekiedy z tendencją do rozpadu. 
Cel pracy: Celem pracy jest przedstawienie przypadku pacjentki z rozpoznanym nowotworem piersi przebiegającym z zajęciem skóry. 
Opis przypadku: 48-letnia pacjentka została przyjęta do Kliniki Dermatologii w celu diagnostyki i leczenia zmian skórnych o charakterze 
licznych sinofioletowych guzków z tendencją do rozpadu oraz owrzodzeń zlokalizowanych na skórze gładkiej klatki piersiowej. W badaniu 
USG piersi całość obrazu przemawiała za procesem nowotworowym pierwotnie wywodzącym się z piersi lewej, z progresją zmian na 
stronę prawą, z licznymi guzkami satelitarnymi. Pobrano w całości guzek do badania histopatologicznego oraz immunohistochemicznego 
w celu ustalenia rozpoznania ostatecznego. Wynik badania histopatologicznego potwierdził rozpoznanie przerzutów nowotworowych 
do skóry, dodatnie odczyny immunohistochemiczne dla cytokeratyny 7 (CK 7) i receptorów estrogenowych (ER) wskazywały na sutek 
jako miejsce guza pierwotnego. Pacjentka została w trybie pilnym skierowana do Centrum Onkologii. 
Wnioski: Wystąpienie przerzutów do skóry w przypadku wszystkich procesów nowotworowych znacznie pogarsza rokowanie pacjenta. 
Zmiany te powinny być szybko rozpoznane przez prowadzącego onkologa lub dermatologa. Czasem punkt wyjścia nowotworu nie jest 
możliwy do ustalenia bez pobrania materiału do badania histopatologicznego i immunohistochemicznego. Szybkie wdrożenie odpow-
iedniej chemioterapii lub radioterapii pozwala przedłużyć życie chorych oraz zmniejszyć dolegliwości bólowe. 
Forum Derm. 2017; 3: 3, 75–78
Słowa kluczowe: przerzuty nowotworów do skóry, rak piersi, guzki satelitarne
Corresponding author:
Agnieszka Białecka, Chair of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Faculty of Medicine in Bydgoszcz,  
Nicolaus Copernicus University in Toruń, Skłodowskiej-Curie 9, 85–094, Bydgoszcz, Polska, e-mail: agnieszka_bialecka@wp.pl
76
Forum Dermatologicum 2017, tom 3, nr 3
Cutaneous metastases originating from tumours of 
internal organs are relatively uncommon. They are usu-
ally a symptom of an advanced malignancy and indicate 
involvement of other internal organs, or may be observed 
in course of recurrence following an ineffective treatment. 
We present a case of a female patient with massive thoracic 
skin metastases as the first symptom of a breast cancer. 
The 48-years old female patient was admitted to The 
Department of Dermatology for diagnosis and treatment 
of dermal lesions in form of numerous blue-purple nodules 
and ulcerations localised on the skin of the chest (Fig. 1 A). 
The patient noticed first dermal eruption just 2 months be-
fore the admission and in this period of time she observed 
development of new nodular lesions and growth of existing 
ones. The patient reported also a body weight loss of appro-
ximately 2 kg over the past year and an excessive sweating 
at night with no other relevant  symptoms. There were no 
abnormalities in the basic laboratory tests. Staphylococ-
cus aureus was cultured from ulceration swabs. Ultrasound 
examination of breasts demonstrated a proliferative lesion 
qualified as BI-RADS (Breast Imaging-Reporting and Data Sys-
tem) 5, suggesting highly probable malignant lesion requ-
iring further diagnostic procedures. The overall ultrasound 
examination suggested a primary malignant lesion in the 
left breast spreading  to the right side, causing ulcerations, 
skin eruptions with tendency to necrosis and numerous 
satellite nodules. Ultrasound examination of peripheral 
lymph nodes revealed pathological packs of lymph nodes 
within axillary fossae and within supra- and infraclavicular 
fossae suggesting an active proliferative process. Other 
lymph nodes available for examination demonstrated no 
typical metastatic changes. Ultrasound examination of the 
abdomen showed no pathologies. X-ray of the chest reve-
aled two symmetrical, round-shaped shadows in the area 
of pulmonary hili. Subsequent scopy indicated that they 
corresponded to shadows of nipples. Performed imaging 
diagnostics did not reveal any metastatic changes within 
internal organs. A whole nodule was collected for histopa-
thological and immunohistochemical examinations in order 
to make the final diagnosis. Histopathology tests confirmed 
the diagnosis of tumour metastases of the skin (Fig. 1 B) and 
positive immunohistochemical reactions for cytokeratin 
7 (CK7) and for oestrogen receptors (ER) pointed mammary 
glands as the primary site (Fig. 2 A, C, D). A negative reaction 
was obtained for human melanoma black 45 (HMB 45),  thy-
roid transcription factor 1 (TTF 1), cytokeratin 20 (CK20) (Fig. 
2 B), and caudal-related homeobox gene 2 (CDX2). Additio-
nal immunohistochemical tests demonstrated a  positive 
reaction for cytokeratin AE/AE3 (CKAE1/AE3) and epithelial 
membrane antigen (EMA), and negative IHC reactions for 
cluster of differentiation 20, 3 and 68 (CD20, CD3, CD68). The 
patient was urgently referred to the Oncology Centre. The 
patient wasn’t present at the scheduled control visit in the 
Dermatology Clinic. Therefore, there are no data regarding 
her further therapeutic process.
Depending on a source it is estimated that cutaneous 
metastases develop in 0.6 to 10.4% of cancer patients [1–4]. 
Therefore, they are relatively uncommon. That broad range 
of data may be a result of the fact that some classifications 
exclude metastatic lesions associated with haematological 
cancers and skin metastases secondary to melanomas. Cu-
taneous metastases may occur in a  patient already dia-
gnosed with cancer, may appear as a first symptom of the 
disease or may be a manifestation of recurrence following 
Figure 1. A. Extensive skin lesions on the chest. B. HE × 10  in the dermis visible slot tumour cells, focally forming glandular structures
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Figure 2. Immunohistochemistry showed positive reactions for CKPan (A), CK7 (C) and ER (D) and negative for CK20 (B), which indicates the breast 
as a source of skin metastases
an ineffective treatment. In women skin metastases are the 
most commonly associated with mammary, ovary, oral, lung 
and colonic cancers. In men they are often associated with 
lung, colonic, oral, renal, mammary, oesophageal, pancre-
atic, stomach and liver cancers [1]. Eventually in children 
cutaneous metastases are most commonly observed se-
condary to neuroblastoma and leukaemia [3, 5]. Cutaneous 
metastases may form papules, scales and blisters. However, 
the most common are metastatic lesions in form of blue-
-purple nodules and tumours, sometimes with a tendency 
to necrosis and formation of extensive ulcerations. In some 
cases the diagnosis of metastatic skin eruptions involves 
dermatoscopic examination demonstrating a pathological 
vascular pattern of a nodular lesion [6]. The examination is 
particularly applicable to patients with metastatic lesions in 
form of single tumours, to be differentiated with primary cu-
taneous tumours, including melanoma, basal cell carcinoma, 
squamous cell carcinoma, Merkel cell carcinoma, or cutane-
ous lymphoma, and with benign dermal lesions, including 
angiomas, granulomas or keloids [6, 7]. In the case of our 
patient the clinical presentation clearly indicated metastatic 
cutaneous changes and suggested breast cancer which is 
the most common female cancer, constituting over 1/5 of all 
cases of tumours. Moreover, it is most commonly associated 
with skin metastases. Metastases usually occur within skin 
of the chest, but they may also develop on extremities or 
within scalp what is probably associated with presence of 
low-pressure and valveless venous vessels in this area [3]. 
Dermal symptoms secondary to breast cancer most often 
involve skin retraction over a tumour, orange skin, infiltra-
tion, ulceration or satellite nodules. Those symptoms were 
present in the discussed case. Presence of satellite nodules 
indicates a significant advancement of cancer or is a sign of 
post-treatment recurrence. It is estimated that skin metasta-
ses secondary to breast cancer are present in approximately 
23.9% of patients [4]. Histopathological and immunohisto-
chemical examinations of skin biopsies play a crucial role in 
the diagnosis. In the discussed case, positive reactions for 
CK7, ER, CKAE1/AE3, EMA, and negative for HMB 45, TTF, 
CK20, CDX2, CD20, CD3, CD68 could indicate lobular breast 
cancer [1], but further studies would be required. Despite 
the recommended preventive examinations, in some cases, 
including ours, only occurrence of visible breast skin lesions 
leads patients to visit a doctor, and constitutes as the first 
symptom of cancer [8]. The diagnosis of cutaneous metasta-
ses indicates usually a high stage of disease advancement 
and is a poor prognostic sign [1]. However, there are cases 
in which cutaneous metastases secondary to mammary 
cancer were isolated [9], or long-term survival was achieved 
[10]. No internal organ lesions were detected in imaging dia-
gnostics procedures in the discussed case. However, some 
more detailed examinations would be required. Considering 
that breast cancer most commonly causes metastases to 
liver, bones, lungs and brain, a CT (computed tomography) 
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scanning of the chest, abdomen, head, and scintiscanning 
are recommended. The treatment of breast cancer patients 
with cutaneous metastases is determined according to the 
Classification of Malignant Tumours (TNM) clinical staging 
of the tumour. Presence of cutaneous metastases indicates 
a poor prognosis. However, it seems not highly significant 
for survival, because it is not associated with major clinical 
complications, as it is in the case for metastases to a cen-
tral nervous system or liver. On the other hand extensive 
tumours and numerous skin nodules with tendency to ne-
crosis may be a  source of serious infections, bleeding or 
other complaints, including pruritus and burning sensation. 
There are reports of necessary amputation of an extremity 
affected by metastases due to severe and life-threatening 
bleeding [11].  The sole mental encounter of skin metastases 
is challenging for the patient. Treatment of skin metastases 
involves a systemic approach — chemotherapy, intratumour 
chemotherapy, radiotherapy or surgical excision of the most 
troublesome skin lesions. A growing collection of evidences 
is recently gathered regarding to applicability of electroche-
motherapy in patients with advanced breast cancer with 
concomitant cutaneous metastases [12]. Each therapeutic 
approach provides a chance for extended survival and im-
proves quality of life. Early diagnosis of the disease is cru-
cial for selection of the best therapeutic option. Currently, 
considering advances in oncotherapy, a dermatologist may 
be the first specialist encountered by a patient with skin 
changes. It is crucial that each suspected lesion, especially 
occurring in a patient whose medical history is burdened 
with cancer, was histopathologically verified.
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